Browsing Tag
Norgine
3 posts
Will mavorixafor’s EU path mirror its U.S. regulatory breakthrough in WHIM syndrome?
X4 Pharmaceuticals (NASDAQ: XFOR) wins EMA backing for mavorixafor. Explore what EU approval could mean for revenue, risk, and rare disease strategy.
March 1, 2026
Olympus Corporation to acquire Arc Medical Design from Norgine
Olympus Corporation, a Japanese optical products company, has agreed to acquire Arc Medical Design, a UK-based subsidiary of…
August 8, 2020
Norgine expands presence in Germany with new office opening in Wettenberg
Dutch pharmaceutical giant Norgine has inaugurated new offices in Wettenberg, Germany, marking a significant step in its ongoing…
July 21, 2018